Discussion
Palatin Technologies expects to begin early-stage clinical trials next year for two experimental treatments designed to curb extreme hunger in people with Prader-Willi syndrome (PWS) and other rare obesity conditions. While Palatin previously anticipated launching these Phase 1 trials this year, the company has pushed the start…